ICA512(IA-2) Epitope Specific Assays Distinguish Transient from Diabetes Associated Autoantibodies
- 31 March 2002
- journal article
- Published by Elsevier in Journal of Autoimmunity
- Vol. 18 (2) , 191-196
- https://doi.org/10.1006/jaut.2001.0577
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Only Multiple Autoantibodies to Islet Cells (ICA), Insulin, GAD65, IA-2 and IA-2β Predict Immune-Mediated (Type 1) Diabetes in RelativesJournal of Autoimmunity, 1999
- Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study.Diabetes, 1999
- Relationship of beta-cell function and autoantibodies to progression and nonprogression of subclinical type 1 diabetes: follow-up of the Seattle Family Study.Diabetes, 1999
- The Melbourne Pre‐Diabetes Study: prediction of type 1 diabetes mellitus using antibody and metabolic testingThe Medical Journal of Australia, 1998
- Prediction of IDDM in the General Population: Strategies Based on Combinations of Autoantibody MarkersDiabetes, 1997
- Value of Antibodies to Islet Protein Tyrosine Phosphatase–Like Molecule in Predicting Type 1 DiabetesDiabetes, 1997
- IA-2-autoantibodies complement GAD 65 -autoantibodies in new-onset IDDM patients and help predict impending diabetes in their siblingsDiabetologia, 1997
- Prediction of Type I Diabetes in First-Degree Relatives Using a Combination of Insulin, GAD, and ICA512bdc/IA-2 AutoantibodiesDiabetes, 1996
- Molecular Cloning and Identification of a Receptor-Type Protein Tyrosine Phosphatase, IA-2, from Human InsulinomaDNA and Cell Biology, 1994
- Cloning and Expression of IDDM-Specific Human AutoantigensDiabetes, 1992